Results 51 to 60 of about 2,327 (198)

Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets [PDF]

open access: yes, 2017
Here, we present a large (n = 107,207) genome-wide association study (GWAS) of general cognitive ability ("g"), further enhanced by combining results with a large-scale GWAS of educational attainment.
Cirulli, Elizabeth T   +223 more
core   +3 more sources

Neuroprotective Effect of Ashtanga Ghrita on Spatial Learning and Memory in Scopolamine-Induced Amnesia in Rat Model

open access: yesJournal of Ayurveda
Introduction: Ashtanga Ghrita (AG), Medhya Rasayana (nervine rejuvenator), is used for the treatment of neurodegenerative disorders. The contents of AG specifically act on Medha (intellect), whereas the lipid part, Go Ghrita, serves as a medium for the ...
Yashika Singh, DevNath Singh Gautam
doaj   +1 more source

Vascular cognitive impairment and dementia drug‐development pipeline 2025

open access: yesAlzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 2, April/June 2026.
Abstract INTRODUCTION There are currently no approved medicines for vascular cognitive impairment and dementia (VCID). METHODS We reviewed clinical trials across nine registries and included, summarized, and evaluated trials that had not yet published peer‐reviewed results by August 22, 2025.
Ying Xu   +2 more
wiley   +1 more source

Green Tea catchins as Neuroprotective Agents: Systematic Review of the Literature in Animal Pre-clinical trials [PDF]

open access: yes, 2015
Alzheimer's Disease (AD) is a neurodegenerative disorder and the most common form of dementia, with symptoms and manifestations that progressively get worse with increasing age. Therefore, with the ageing of the population worldwide, the prevalence of AD
Roach, Paul   +2 more
core   +1 more source

The modern view of the idea of gamma-aminobutyric acid and its metabolite use to restore the motor function

open access: yesPatologìâ, 2015
Aim. The literature review is devoted to the idea of using gamma-aminobutyric acid and its metabolites as medicines in conditions of peripheral nervous system injury.
А. G. Rodinskij   +3 more
doaj   +1 more source

Surveillance of Phenibut in Wastewater During a Brazilian Carnival

open access: yesDrug Testing and Analysis, Volume 18, Issue 2, Page 192-197, February 2026.
This study reports the first detection of phenibut in Brazilian wastewater. Phenibut, a substance readily sold online to improve concentration, reaches wastewater treatment plants (WWTPs) after consumption by the population. Samples from WWTPs in the cities of Recife and Olinda in Northeastern Brazil were collected during the world's largest Carnival ...
Bruna R. de S. Gomes   +5 more
wiley   +1 more source

Health Effects of Bee Products: A Comprehensive Review

open access: yesFood Science &Nutrition, Volume 14, Issue 2, February 2026.
Nutritional composition of bee products and some health effects. ABSTRACT Honey, bee pollen, propolis, bee bread, royal jelly, bee venom, beeswax, and apilarnil are among the bee‐derived products that may serve health‐related purposes, as they exhibit various biological activities such as antibacterial, antiviral, antifungal, antioxidant, anti ...
Nevin Sanlier   +2 more
wiley   +1 more source

<i>Zingiber officinale</i>: evaulation of its Nootropic effect in mice

open access: yes, 2005
Dementia is one of the age-related mental problems, and a characteristic symptom of Alzheimer\'s disease. Nootropic agents and cholinesterase inhibitors like donepezil® are clinically used in situations where there is organic disorder in learning ...
Milind Parle   +3 more
core   +1 more source

Diagnosis and treatment of benign paroxysmal positional vertigo in common clinical practice

open access: yesТерапевтический архив, 2017
Aim. To analyze typical medical practice in managing patients with benign paroxysmal positional vertigo (BPPV). Subjects and methods. 33 patients (5 men and 28 women; mean age, 58 years) with BPPV who had been referred for consultation to the Medical ...
N V Lebedeva   +3 more
doaj   +1 more source

Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl.

open access: yesMedičnì Perspektivi, 2018
Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of com­bined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical ...
V. I. Mamchur, S. N. Dronov
doaj   +1 more source

Home - About - Disclaimer - Privacy